LAVA Therapeutics N.V. (LVTX) Tops Q3 EPS by 15c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.34), $0.15 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen